Search Count: 10
 |
Crystal Structure Of The Fab Fragment Of Pf06438179/Gp1111 An Infliximab Biosimilar In A C-Centered Orthorhombic Crystal Form, Lot A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2019-11-13 Classification: IMMUNE SYSTEM |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-11-13
 |
Crystal Structure Of The Fab Fragment Of Pf06438179/Gp1111 An Infliximab Biosimilar In A I-Centered Orthorhombic Crystal Form, Lot A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2019-11-13 Classification: IMMUNE SYSTEM Ligands: EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-11-13
Ligands: EDO
 |
Crystal Structure Of The Fab Fragment Of Anti-Tnfa Antibody Infliximab (Remicade) In A C-Centered Orthorhombic Crystal Form, Lot C
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2019-11-13 Classification: IMMUNE SYSTEM |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-11-13
 |
Crystal Structure Of The Fab Fragment Of Anti-Tnfa Antibody Infliximab (Remicade) In A I-Centered Orthorhombic Crystal Form, Lot C
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2019-11-13 Classification: IMMUNE SYSTEM Ligands: MRY, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-11-13
Ligands: MRY, EDO
 |
Crystal Structure Of The Fc Fragment Of Pf06438179/Gp1111 An Infliximab Biosimilar In A C-Centered Orthorhombic Crystal Form, Lot A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2019-11-13 Classification: IMMUNE SYSTEM Ligands: ZN, ACT |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-11-13
Ligands: ZN, ACT
 |
Crystal Structure Of The Fc Fragment Of Pf06438179/Gp1111 An Infliximab Biosimilar In A Primative Orthorhombic Crystal Form, Lot A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2019-11-13 Classification: IMMUNE SYSTEM Ligands: K, CL |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-11-13
Ligands: K, CL
 |
Crystal Structure Of The Fc Fragment Of Anti-Tnfa Antibody Infliximab (Remicade) In A Primative Orthorhombic Crystal Form, Lot C
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2019-11-13 Classification: IMMUNE SYSTEM Ligands: ZN, ACT |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-11-13
Ligands: ZN, ACT
 |
Crystal Structure Of Fab Fragment Of The Anti-Tnfa Antibody Infliximab In A C-Centered Orthorhombic Crystal Form
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2017-05-03 Classification: IMMUNE SYSTEM Ligands: EDO |
Organism: Mus musculus
Method: X-RAY DIFFRACTION
Release Date: 2017-05-03
Ligands: EDO
 |
Crystal Structure Of Fab Fragment Of Anti-Tnfa Antibody Infliximab In An I-Centered Orthorhombic Crystal Form
Organism: Mus musculus, homo sapiens, Mus musculus, homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2017-05-03 Classification: IMMUNE SYSTEM Ligands: NAD, EDO |
Organism: Mus musculus, homo sapiens, Mus musculus, homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-05-03
Ligands: NAD, EDO
 |
Crystal Structure Of Fc Fragment Of Anti-Tnfa Antibody Infliximab
Organism: Mus musculus, homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2017-05-03 Classification: IMMUNE SYSTEM Ligands: ZN, ACT |
Organism: Mus musculus, homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-05-03
Ligands: ZN, ACT